Raptor Pharmaceutical's Trial Failed, But Huntington's Disease Update Could Bring Gains At Year End
September 15, 2015 at 09:02 AM EDT
Raptor Pharmaceutical Corp. (NASDAQ: RPTP) shares have plunged 43 percent in the last month, and are trading close to the lower ...